Hormone therapy is not a match for everyone, and it is not something you should start on your own
In October 2025, the Welsh government confirmed plans to develop a new clinical pathway to treat obesity as a chronic, recurring condition and support equitable access to weight-loss drugs and wrap-around care, including in appropriate primary care and community settings 42
Comparative effects of liraglutide 3 mg versus structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: a pilot randomized trial
CMS Medicare Part D Redesign, 2026 Medicare vs
We proudly serve patients in Texas, New York, Florida, Colorado, Maryland, and California
Mitochondrial-endoplasmic reticulum communication-mediated oxidative stress and autophagy